Search Results

By H. KIM LYERLY, MD, FACS; RENZO CANETTA, MD; THOMAS FLEMING, PhD; AND RICHARD L. SCHILSKY, MD, FACP, FSCT, FASCO  / March 2025

Two Decades of Collaboration: The Accelerating Anticancer Agent Development and Validation (AAADV) Workshop

Over the past 20 years, the investment in research and development of cancer therapies has been unprecedented, and the pace of new drug development has been accelerating. To illustrate this trajectory, the U.S. Food and Drug Administration (FDA) approved 71 treatments for solid cancers in adults...